Valeant Pharmaceuticals announced that the company will change its name to Bausch Health Companies Inc., effective July 2018.
As part of the name change, the Company will roll out a new corporate brand identity in July 2018, which will include new imagery and web site, and will trade under the new symbol, BHC. Until that time, the company will continue to trade on the Toronto Stock Exchange under the present symbol VRX.
“Becoming Bausch Health Companies is a major step forward in our transformation,” said Joseph C. Papa, chairman and CEO, Valeant.
“We completed an extensive assessment of the name entities available from within our portfolio and also assessed several potential new names. As our review progressed, it became clear that Bausch Health Companies best represents the company we are today,” said Mr. Papa.